|
1
|
DeSantis CE, Lin CC, Mariotto AB, Siegel
RL, Stein KD, Kramer JL, Alteri R, Robbins AS and Jemal A: Cancer
treatment and survivorship statistics, 2014. CA Cancer J Clin.
64:252–271. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hato T, Goyal L, Greten TF, Duda DG and
Zhu AX: Immune checkpoint blockade in hepatocellular carcinoma:
Current progress and future directions. Hepatology. 60:1776–1782.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Serag HB and Kanwal F: Epidemiology of
hepatocellular carcinoma in the United States: Where are we? Where
do we go? Hepatology. 60:1767–1775. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marshall GM, Bell JL, Koach J, Tan O, Kim
P, Malyukova A, Thomas W, Sekyere EO, Liu T, Cunningham AM, et al:
TRIM16 acts as a tumour suppressor by inhibitory effects on
cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.
Oncogene. 29:6172–6183. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bell JL, Malyukova A, Holien JK, Koach J,
Parker MW, Kavallaris M, Marshall GM and Cheung BB: TRIM16 acts as
an E3 ubiquitin ligase and can heterodimerize with other TRIM
family members. PLoS One. 7:e374702012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sutton SK, Koach J, Tan O, Liu B, Carter
DR, Wilmott JS, Yosufi B, Haydu LE, Mann GJ, Thompson JF, et al:
TRIM16 inhibits proliferation and migration through regulation of
interferon beta 1 in melanoma cells. Oncotarget. 5:10127–10139.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cheung BB, Koach J, Tan O, Kim P, Bell JL,
D'andreti C, Sutton S, Malyukova A, Sekyere E, Norris M, et al: The
retinoid signalling molecule, TRIM16, is repressed during squamous
cell carcinoma skin carcinogenesis in vivo and reduces skin cancer
cell migration in vitro. J Pathol. 226:451–462. 2012. View Article : Google Scholar :
|
|
9
|
You H, Ding W and Rountree CB: Epigenetic
regulation of cancer stem cell marker CD133 by transforming growth
factor-beta. Hepatology. 51:1635–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang
P, He X, Wang Q, Huang Y, Jen KY, et al: CUL4A induces
epithelial-mesenchymal transition and promotes cancer metastasis by
regulating ZEB1 expression. Cancer Res. 74:520–531. 2014.
View Article : Google Scholar :
|
|
11
|
Wang Y, Zhang P, Liu Z, Wang Q, Wen M,
Wang Y, Yuan H, Mao JH and Wei G: CUL4A overexpression enhances
lung tumor growth and sensitizes lung cancer cells to erlotinib via
transcriptional regulation of EGFR. Mol Cancer. 13:2522014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun Y, Wang Y, Fan C, Gao P, Wang X, Wei G
and Wei J: Estrogen promotes stemness and invasiveness of
ER-positive breast cancer cells through Gli1 activation. Mol
Cancer. 13:1372014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Floor S, van Staveren WC, Larsimont D,
Dumont JE and Maenhaut C: Cancer cells in epithelial-to-mesenchymal
transition and tumor-propagating-cancer stem cells: Distinct,
overlapping or same populations. Oncogene. 30:4609–4621. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hills CE and Squires PE: The role of TGF-β
and epithelial-to mesenchymal transition in diabetic nephropathy.
Cytokine Growth Factor Rev. 22:131–139. 2011.PubMed/NCBI
|
|
16
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huo X, Li S, Shi T, Suo A, Ruan Z and Yao
Y: Tripartite motif 16 inhibits epithelial-mesenchymal transition
and metastasis by down-regulating sonic hedgehog pathway in
non-small cell lung cancer cells. Biochem Biophys Res Commun.
460:1021–1028. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Zijl F, Zulehner G, Petz M, Schneller
D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H and Mikulits
W: Epithelial-mesenchymal transition in hepatocellular carcinoma.
Future Oncol. 5:1169–1179. 2009. View Article : Google Scholar : PubMed/NCBI
|
